table of content
1 Study Coverage
1.1 CINV Existing and Pipeline Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aloxi
1.2.3 Zofran Generic
1.2.4 Kytril Generic
1.2.5 Emend
1.2.6 Akynzeo
1.2.7 SUSTOL
1.2.8 Rolapitant
1.3 Market by Application
1.3.1 Global CINV Existing and Pipeline Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers Therapeutics
1.3.5 Hospital Pharmacies
1.3.6 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CINV Existing and Pipeline Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global CINV Existing and Pipeline Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global CINV Existing and Pipeline Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global CINV Existing and Pipeline Drugs Sales by Region
2.4.1 Global CINV Existing and Pipeline Drugs Sales by Region (2017-2022)
2.4.2 Global Sales CINV Existing and Pipeline Drugs by Region (2023-2028)
2.5 Global CINV Existing and Pipeline Drugs Revenue by Region
2.5.1 Global CINV Existing and Pipeline Drugs Revenue by Region (2017-2022)
2.5.2 Global CINV Existing and Pipeline Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global CINV Existing and Pipeline Drugs Sales by Manufacturers
3.1.1 Global Top CINV Existing and Pipeline Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global CINV Existing and Pipeline Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CINV Existing and Pipeline Drugs in 2021
3.2 Global CINV Existing and Pipeline Drugs Revenue by Manufacturers
3.2.1 Global CINV Existing and Pipeline Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by CINV Existing and Pipeline Drugs Revenue in 2021
3.3 Global CINV Existing and Pipeline Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global CINV Existing and Pipeline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global CINV Existing and Pipeline Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CINV Existing and Pipeline Drugs Sales by Type
4.1.1 Global CINV Existing and Pipeline Drugs Historical Sales by Type (2017-2022)
4.1.2 Global CINV Existing and Pipeline Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global CINV Existing and Pipeline Drugs Sales Market Share by Type (2017-2028)
4.2 Global CINV Existing and Pipeline Drugs Revenue by Type
4.2.1 Global CINV Existing and Pipeline Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global CINV Existing and Pipeline Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global CINV Existing and Pipeline Drugs Revenue Market Share by Type (2017-2028)
4.3 Global CINV Existing and Pipeline Drugs Price by Type
4.3.1 Global CINV Existing and Pipeline Drugs Price by Type (2017-2022)
4.3.2 Global CINV Existing and Pipeline Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global CINV Existing and Pipeline Drugs Sales by Application
5.1.1 Global CINV Existing and Pipeline Drugs Historical Sales by Application (2017-2022)
5.1.2 Global CINV Existing and Pipeline Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global CINV Existing and Pipeline Drugs Sales Market Share by Application (2017-2028)
5.2 Global CINV Existing and Pipeline Drugs Revenue by Application
5.2.1 Global CINV Existing and Pipeline Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global CINV Existing and Pipeline Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global CINV Existing and Pipeline Drugs Revenue Market Share by Application (2017-2028)
5.3 Global CINV Existing and Pipeline Drugs Price by Application
5.3.1 Global CINV Existing and Pipeline Drugs Price by Application (2017-2022)
5.3.2 Global CINV Existing and Pipeline Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America CINV Existing and Pipeline Drugs Market Size by Type
6.1.1 North America CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
6.1.2 North America CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
6.2 North America CINV Existing and Pipeline Drugs Market Size by Application
6.2.1 North America CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
6.2.2 North America CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
6.3 North America CINV Existing and Pipeline Drugs Market Size by Country
6.3.1 North America CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
6.3.2 North America CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe CINV Existing and Pipeline Drugs Market Size by Type
7.1.1 Europe CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
7.1.2 Europe CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
7.2 Europe CINV Existing and Pipeline Drugs Market Size by Application
7.2.1 Europe CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
7.2.2 Europe CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
7.3 Europe CINV Existing and Pipeline Drugs Market Size by Country
7.3.1 Europe CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
7.3.2 Europe CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Type
8.1.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Application
8.2.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific CINV Existing and Pipeline Drugs Market Size by Region
8.3.1 Asia Pacific CINV Existing and Pipeline Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific CINV Existing and Pipeline Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America CINV Existing and Pipeline Drugs Market Size by Type
9.1.1 Latin America CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
9.1.2 Latin America CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
9.2 Latin America CINV Existing and Pipeline Drugs Market Size by Application
9.2.1 Latin America CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
9.2.2 Latin America CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
9.3 Latin America CINV Existing and Pipeline Drugs Market Size by Country
9.3.1 Latin America CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
9.3.2 Latin America CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Type
10.1.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Application
10.2.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa CINV Existing and Pipeline Drugs Market Size by Country
10.3.1 Middle East and Africa CINV Existing and Pipeline Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa CINV Existing and Pipeline Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Overview
11.2.3 Helsinn CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Helsinn CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Helsinn Recent Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Corporation Information
11.3.2 Heron Therapeutics Overview
11.3.3 Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Heron Therapeutics CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Heron Therapeutics Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Tesaro
11.5.1 Tesaro Corporation Information
11.5.2 Tesaro Overview
11.5.3 Tesaro CINV Existing and Pipeline Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tesaro CINV Existing and Pipeline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tesaro Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CINV Existing and Pipeline Drugs Industry Chain Analysis
12.2 CINV Existing and Pipeline Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CINV Existing and Pipeline Drugs Production Mode & Process
12.4 CINV Existing and Pipeline Drugs Sales and Marketing
12.4.1 CINV Existing and Pipeline Drugs Sales Channels
12.4.2 CINV Existing and Pipeline Drugs Distributors
12.5 CINV Existing and Pipeline Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 CINV Existing and Pipeline Drugs Industry Trends
13.2 CINV Existing and Pipeline Drugs Market Drivers
13.3 CINV Existing and Pipeline Drugs Market Challenges
13.4 CINV Existing and Pipeline Drugs Market Restraints
14 Key Findings in The Global CINV Existing and Pipeline Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
